Hevert-Arzneimittel achieves record sales

Hevert-Arzneimittel attains double-digit growth and record sales: in 2013, the specialist in naturopathy increased sales revenues by 15.8 percent to slightly over EUR20 million.

The co-owners of Hevert-Arzneimittel Sarah, Mathias and Marcus Hevert are pleased about the record sales.

The Nussbaum-based pharmaceutical company said that the rise had been driven by good performances from its Top OTC products in pharmacies and from the compliance of doctors and homeopaths in prescribing Hevert products.

“Above all, our vitamin products contributed to this excellent development,” Mathias Hevert, managing director, remarks. In 2013, sales of the company’s vitamin-based products increased by 44%. Turnover from homoeopathic OTC remedies further contributed to the growth.

The headquarters of Hevert-Arzneimittel at Nussbaum.

To expand the position in the German home market and to open up new foreign markets – these are the goals for 2014. The expansion of production capacity at the headquarters in Nussbaum, Rhineland-Palatinate, proceeds as scheduled. “Construction work should be completed by early April,” Mathias Hevert states. “With the new production facilities we have set the course for adding further export markets and prepared for growing demand. Currently, we are working at the introduction of the two homoeopathic brands Sinusitis Hevert and Pulmo Hevert in Ukraine.”

This website uses cookies. By using this website, you consent to the use of cookies in accordance with our policy. OK